- Home
- FLEX vs PODD Comparison
FLEX vs PODD Comparison
Compare FLEX & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FLEX | PODD |
|---|---|---|
| Founded | 1990 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.6B | 22.1B |
| IPO Year | 1994 | 2007 |
Fundamental Metrics
Financial Performance| Metric | FLEX | PODD |
|---|---|---|
| Price | $68.70 | $294.62 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 19 |
| Target Price | $59.33 | ★ $359.00 |
| AVG Volume (30 Days) | ★ 5.5M | 762.5K |
| Earning Date | 01-28-2026 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.03 | N/A |
| EPS | 2.28 | ★ 3.45 |
| Revenue | ★ $26,333,000,000.00 | $2,521,800,000.00 |
| Revenue This Year | $7.15 | $32.55 |
| Revenue Next Year | $6.01 | $20.39 |
| P/E Ratio | ★ $30.03 | $85.28 |
| Revenue Growth | 3.47 | ★ 27.11 |
| 52 Week Low | $25.11 | $230.05 |
| 52 Week High | $70.37 | $354.88 |
Technical Indicators
Market Signals| Indicator | FLEX | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 68.69 | 36.56 |
| Support Level | $56.17 | $303.20 |
| Resistance Level | $59.57 | $317.34 |
| Average True Range (ATR) | 2.62 | 13.35 |
| MACD | 1.22 | -3.79 |
| Stochastic Oscillator | 89.57 | 0.13 |
Price Performance
Historical ComparisonAbout FLEX Flex Ltd.
Flex Ltd is a contract manufacturing company providing comprehensive electronics design, manufacturing, and product management services to electronics and technology companies. The company's operating segments include Flex Agility Solutions (FAS) and Flex Reliability Solutions (FRS). Flex Agility Solutions segment includes markets such as Communications, Enterprise and Cloud; Lifestyle; and Consumer Devices. Flex Reliability Solutions segment includes markets such as Automotive, Health Solutions, and Industrial.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.